|

Add a bookmark to get started

Bookmarks info
People default image

Jenna Fontenot

Associate
Miami
About

Jenna Fontenot is a corporate lawyer and former neurosurgery nurse, representing clients in a broad range of transactions and other corporate and securities law matters. 

Jenna advises public company clients across industries on SEC reporting and disclosure requirements, shareholder activism and engagement, and other securities law and stock exchange compliance matters. She also counsels public companies on a variety of corporate governance matters, including board composition and procedures, environmental, social and governance (ESG), internal and disclosure controls, insider trading and other topics. Jenna also represents investment banks as well as public and private companies, primarily in the life sciences and technology industries, in a variety of transactions including IPOs and other primary and secondary offerings, private placements, transactions involving SPACs, tender offers, mergers and acquisitions, and other transactions.

Areas of FocusCorporateHealthcareLife Sciences TransactionsEnvironmental, Social and GovernanceEquity Capital MarketsFinancial ServicesLife SciencesMergers and AcquisitionsPrivate EquityTechnology
Bar admissionsNew YorkFlorida

EXPERIENCE

Jenna has represented:

  • NewAmsterdam Pharma in its $726 million business combination with Frazier Lifesciences.*
  • Evercore and William Blair as lead book-runners in the Nasdaq IPO of MiNK Therapeutics.*
  • LanzaTech in its $2.2 billion deSPAC merger.*
  • Goldman Sachs, Morgan Stanley and other underwriters in an upsized $201 million follow-on offering by Bicycle Therapeutics.*
  • Adit EdTech in a $3.3 billion deSPAC merger with Griid Infrastructure.*
  • Selecta Biosciences in a $39 million follow-on offering.*
  • Cantor Fitzgerald and RBC as underwriters in a $100 million at-the-market offering and a $30 million follow-on offering for MindMed, Inc.*
  • Jefferies and Cowen as underwriters in connection with Quotient Ltd.’s follow-on and at-the-market offerings.*
  • Cantor Fitzgerald in connection with Marker Therapeutics’ at-the-market offering.*
  • Global Pharmaceutical and other life sciences companies in connection with SEC public reporting and corporate governance matters.

*Matters handled prior to DLA Piper

Education
  • J.D., Tulane University, cum laude
    Tulane Maritime Law Journal    , Senior Editor
  • B.S.N., Southeastern Louisiana University

Pro Bono

Jenna counsels charitable organizations in connection with corporate matters.

Prior Experience

Prior to practicing law, Jenna practiced as a registered neurosurgery nurse at the Tulane Center for Clinical Neurosciences.

My latest insights

News

DLA Piper advises Initial Purchasers, led by Cantor Fitzgerald & Co., in $500 Million...

28 October 2024 .2 minute read

News

DLA Piper advises Cantor Fitzgerald in Zura Bio’s warrant exchange offer and consent...

14 August 2024 .1 minute read

Publication

PCAOB proposes new auditing standard: Action steps for public companies

17 June 2024 .6 minute read

View All

Connect

Phone

+1 305 423 8577
(Work, Miami)
CallvCardLinkedInPrint
Legal noticesPrivacy policyCookie policyFraud AlertSitemap

DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper's structure, please refer to the Legal Notices page of this website. All rights reserved. Attorney advertising.

© 2024 DLA Piper